Max Healthcare delays Gurgaon hospital, cuts oncology revenue outlook
Management now expects the 500-bed Gurgaon facility by end-FY27, not H1. Oncology's share of revenue is seen stabilising at 21-22%, down from a prior 25-26%.
— 3 earlier stories on Max Healthcare Institute Ltd. →What's new
- Gurgaon greenfield hospital commissioning delayed by ~6 months to end-FY27.
- Oncology revenue mix outlook cut to 21-22% from 25-26% due to CGHS drug pricing.
- Brownfield capacity additions of 20%+ remain on track across the network.
Why this matters
The Gurgaon delay is a modest pushback, but the oncology mix revision is structural. It ties directly to a regulatory change (CGHS pricing) that won't reverse, trimming a high-margin segment's contribution to the revenue base. This changes the margin trajectory for the hospital network.
What we're watching
- Whether the ₹1,400 cr Lucknow project faces similar timeline slippage.
- Margin impact as lower-margin non-oncology volume makes up the revenue mix.
- Execution on the 20%+ brownfield capacity additions this fiscal.
The full read
Max Healthcare's conference call contained two downward revisions. The 500-bed Gurgaon greenfield hospital will now be commissioned by end-FY27, not H1 as previously guided, a six-month delay. More consequentially, management flagged a permanent shift in its oncology revenue mix. The segment will stabilise at 21-22% of revenue, down from a prior 25-26%, due to CGHS drug pricing changes. That's a structural hit to a high-margin business line. The remaining guidance was steady: brownfield additions of 20%+ are on track, and the ₹1,400 crore Lucknow greenfield is progressing on schedule. The oncology revision is the one to watch. CGHS pricing pressure doesn't abate, and it reshapes the revenue mix toward lower-margin general medicine.
Questions answered
- Why is Max Healthcare's oncology revenue share falling?
- Management cited changes to CGHS drug pricing. This regulatory adjustment is lowering the revenue contribution from oncology, which is now expected to stabilise at 21-22% of the mix, down from a prior 25-26% range.
- How significant is the Gurgaon hospital delay?
- The 500-bed greenfield hospital is now expected by end-FY27, a delay from the earlier H1 FY27 guidance. This pushes back the capacity addition by roughly six months within the current fiscal year.
- Is the Lucknow hospital still on schedule?
- Yes. The board-approved ₹1,400 crore greenfield hospital in Lucknow is progressing on schedule, management stated on the call.
- What is the status of the company's brownfield expansion?
- Brownfield capacity rollout remains on track, with management guiding for 20%+ additions across its network of existing facilities.
Max Healthcare Institute Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on MAXHEALTH →- 22 May 2026 · 12:22 PM IST Max Healthcare delays Gurgaon hospital, cuts oncology revenue outlook
- 46d ago Max Healthcare posts 10% revenue growth, maps ₹1,400 cr Lucknow greenfield hospital
- 46d ago Max Healthcare revenue up 16% in FY26, unveils ₹1,400 cr Lucknow hospital
- 46d ago Max Healthcare to build ₹1,400 cr hospital in Lucknow